West Pharmaceutical Services (WST)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 3 |
| Ownership rank: | 299 |
| % of all portfolios: | 0.028% |
| Hold Price * : | $250.63 |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q1 2026 | |||||
| ≡ | Viking Global Investors | Add 41.32% | 121,920 | 0.08 | |
| Q4 2025 | |||||
| ≡ | Viking Global Investors | Buy | 295,028 | 0.22 | |
| Q3 2025 | |||||
| ≡ | Henry Ellenbogen - Durable Capital Partners | Add 12.68% | 131,935 | 0.26 | |
| ≡ | Hillman Capital Management | Buy | 10,273 | 1.57 | |
| Q1 2025 | |||||
| ≡ | Henry Ellenbogen - Durable Capital Partners | Add 146.80% | 935,721 | 1.87 | |
| ≡ | Bill & Melinda Gates Foundation Trust | Buy | 444,500 | 0.24 | |
| Q3 2024 | |||||
| ≡ | Henry Ellenbogen - Durable Capital Partners | Add 4.36% | 45,395 | 0.10 | |
| Q2 2024 | |||||
| ≡ | Henry Ellenbogen - Durable Capital Partners | Add 0.92% | 9,471 | 0.03 | |
| Q1 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 994 | 0.01 | |
| Q2 2023 | |||||
| ≡ | Henry Ellenbogen - Durable Capital Partners | Add 2.96% | 36,757 | 0.12 | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 1790.80% | 1,558 | 0.01 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 87 | 0.00 | |
| Q4 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 137.07% | 57,790 | 0.08 | |
| Q3 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 42,160 | 0.06 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.